Dates and moringa show promise for postpartum depression and breast milk
NCT ID NCT07337512
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether eating dates or taking moringa can help new mothers with postpartum depression. 363 mothers with mild to severe depression and low breast milk production were split into three groups: dates, moringa, or a control group. After 28 days, researchers measured changes in depression scores, stress hormone levels, and breast milk volume.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dates (Phoenix dactylifera L.) and Moringa oleifera
- What this could lead to
- If it works, this could offer a natural, food-based option to help ease postpartum depression and improve breast milk production.
- What could go wrong
- This is a completed trial, but the results are not yet widely confirmed. The effects may be modest, and individual results can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
363 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Eligibility Criteria: Inclusion Criteria: * Individuals aged 18-35 years * Mothers with infants aged 2 weeks to 6 months * Body Mass Index (BMI) greater than 18.7 * Scores on the Beck Depression Inventory (BDI) ranging from mild to severe depression * Breast milk production of less than 300 g/day Exclusion Criteria: * Mothers with endocrine disorders * Acute or chronic diseases * Conditions such as hypoplastic breast tissue * Use of combined estrogen contraceptives * Mothers who smoke or consume alcohol
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postpartum depression (PPD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Poltekkes Kemenkes Kendari
Kendari, Southeast Sulawesi, 93231, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill ease severe postpartum depression?
- Could more doula visits ease postpartum depression?
- A healing hand: could Doula-Midwife teams transform postpartum recovery for NICU moms?
- Magnetic pulses to the brain: a Drug-Free hope for peripartum depression?
- Can a wearable light device lift the fog of postpartum depression?
- Can a Three-Day pill ease postpartum depression?